Latest news

Category: Health professionals

Health professionals

NICE launches review of methods and processes for health technology evaluation

Stakeholders can comment until 13 October on the most wide-ranging and comprehensive review NICE has ever carried out. The public consultations cover proposed changes to the way NICE develops recommendations across its health technology evaluation programmes and proposals to clarify the topic selection and routing criteria used to determine what treatments, devices or diagnostics are selected for NICE guidance development.

Health professionals

The Essential Cholesterol Programme for Primary Care

Join an afternoon session on an introduction to the basics of cholesterol at the HEART UK conference on 20 July

Understanding cholesterol results
Spotlight on diet and its impact on cholesterol
The impact of diet on cholesterol
Diet and cholesterol: from science to practice
Diabetes and cholesterol: exploring dietary factors.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Find out more on the HEART UK conference pages. The Health Professional area of the website is intended only for healthcare professionals.

Health professionals

Add on to take back control. Do we have the solutions to the gaps in our lipid treatment pathway?

Dr Derek Connolly, Consultant Interventional Cardiologist and the Director of Research and Development at Birmingham City Hospital will chair a session exploring solutions to the gaps in lipid treatment with speaker Dr Susan Connolly, Consultant Cardiologist at Enniskillen.

Find out more on the HEART UK conference programme of the HCP pages. The Health Professional area of the website is intended only for healthcare professionals.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Health professionals

Familial Hypercholesterolaemia: from Epidemiology to Genetics – a paradigm shift?

Clinical Certainties and Uncertainties: what remains unresolved?

We are delighted that Professor Andrew Neil, Emeritus Professor of Clinical Epidemiology University of Oxford, Wolfson College will speak at the HEART UK conference on 7 July.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Health professionals

The role of Lp(a) and oxPLs in atherosclerosis

We are delighted to welcome Prof Sotirios (Sam) TSIMIKAS to the HEART UK conference on 7 July to present current and future therapeutic agents and interventions targeting Lp(a) and oxPLs.

Find out more on our HEART UK conference programme on the HCP pages. The Health Professional area of the website is intended only for healthcare professionals.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Health professionals

Lp(a) measurement bias

Over and underestimation of Lp(a) due to its different molecular weight isoforms has led to bias in many studies leading to underestimation of its strength as a cardiovascular risk factor.

Find out more on our HEART UK conference pages. The Health Professional area of the website is intended only for healthcare professionals.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Health professionals

Polygenic hypercholesterolaemia: why do we want to know?

Prof Steve HUMPHRIES will be presenting at the HEART UK conference on Wednesday 7th July.

How knowing that a patient with clinical FH has a polygenic and not a monogenic cause for their phenotype is key in the clinician deciding on the appropriate patient care pathway.

Find out more on our HEART UK conference pages. The Health Professional area of the website is intended only for healthcare professionals.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Health professionals

HEART UK Offers Guidance On The Safe Use Of Lipid Lowering Therapy During COVID-19 Pandemic

In the absence of evidence from a high-quality clinical trial, a consensus statement by HEART UK provides a guide for managing hyperlipidaemia during the pandemic, based on available evidence and experts’ opinion.

Health professionals

Ketogenic Diet and Lipids

Historically a ketogenic diet was used to treat epilepsy in children. More recently, it has become popular as a way to lose weight and manage Type II Diabetes. We take a look at its effect on weight and cardiometabolic risk factors.

1
2
3
4
5
6
7